Genetesis Is A Clinical Stage Medical Device Company Dedicated To Advancing Cardiac Imaging Through Biomagnetic Technologiesfounded In 2013 By A Group Of Friends From Ohio State Universitythe Company Is Based In Buffalonew Yorkand Has Grown To A Team Of Over 20 Employees With $40 Million In Funding As Of 2023 The Company Specializes In Cardioflux Mcga Non Invasive Magnetocardiography System That Detects Coronary Artery Disease By Measuring The Heartae S Magnetic Fieldthis Innovative Technology Aims To Replace Traditional Radiation Based Imaging Methodsproviding A Safer And More Efficient Diagnostic Toolcardioflux Has Received Fda Breakthrough Device Designationhighlighting Its Potential To Meet Critical Clinical Needsgenetesis Targets Hospitals And Cardiology Clinicsfocusing On Enhancing Patient Care Through Advanced Imaging Solutions
